Oaktree Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-134,000
| Closed | -$48.2K | – | 299 |
|
|
2023
Q1 | $48.2K | Hold |
134,000
| – | – | ﹤0.01% | 292 |
|
|
2022
Q4 | $119K | Hold |
134,000
| – | – | ﹤0.01% | 338 |
|
|
2022
Q3 | $210K | Hold |
134,000
| – | – | ﹤0.01% | 374 |
|
|
2022
Q2 | $269K | Sell |
134,000
-16,000
| -11% | -$32.1K | ﹤0.01% | 353 |
|
|
2022
Q1 | $349K | Hold |
150,000
| – | – | ﹤0.01% | 342 |
|
|
2021
Q4 | $697K | Buy |
150,000
+16,000
| +12% | +$74.3K | 0.01% | 319 |
|
|
2021
Q3 | $1.02M | Hold |
134,000
| – | – | 0.01% | 231 |
|
|
2021
Q2 | $1.3M | Sell |
134,000
-186,000
| -58% | -$1.8M | 0.02% | 177 |
|
|
2021
Q1 | $2.65M | Buy |
+320,000
| New | +$2.65M | 0.04% | 162 |
|
|
2020
Q3 | – | Sell |
-100,500
| Closed | -$631K | – | 197 |
|
|
2020
Q2 | $631K | Buy |
+100,500
| New | +$631K | 0.01% | 178 |
|